SECTOR GAMMA AS - Q2 2017 holdings

$688 Million is the total value of SECTOR GAMMA AS's 26 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 15.4% .

 Value Shares↓ Weighting
ABT BuyABBOTT LABS$74,730,000
+27.6%
1,537,342
+16.6%
10.86%
+16.7%
BAX BuyBAXTER INTL INC$64,798,000
+20.6%
1,070,333
+3.3%
9.42%
+10.2%
BMY BuyBRISTOL MYERS SQUIBB CO$49,557,000
+16.5%
889,390
+13.7%
7.20%
+6.5%
PKI BuyPERKINELMER INC$43,017,000
+18.8%
631,308
+1.3%
6.25%
+8.7%
BSX BuyBOSTON SCIENTIFIC CORP$39,847,000
+12.5%
1,437,480
+1.0%
5.79%
+2.9%
LLY SellLILLY ELI & CO$39,113,000
-29.7%
475,250
-28.1%
5.69%
-35.7%
GILD BuyGILEAD SCIENCES INC$38,815,000
+27.4%
548,390
+22.3%
5.64%
+16.5%
IRWD SellIRONWOOD PHARMACEUTICALS INC$34,609,000
+4.5%
1,833,097
-5.5%
5.03%
-4.4%
SHPG BuySHIRE PLCsponsored adr$34,353,000
+9.1%
207,861
+15.0%
4.99%
-0.3%
ANTM SellANTHEM INC$33,752,000
-0.3%
179,410
-12.3%
4.91%
-8.8%
IART BuyINTEGRA LIFESCIENCES HLDGS C$26,886,000
+30.7%
493,230
+1.0%
3.91%
+19.5%
BIO BuyBIO RAD LABS INCcl a$26,013,000
+14.4%
114,942
+0.8%
3.78%
+4.6%
PRGO BuyPERRIGO CO PLC$22,138,000
+34.8%
293,140
+18.5%
3.22%
+23.2%
MCK BuyMCKESSON CORP$19,103,000
+11.8%
116,100
+0.8%
2.78%
+2.2%
MASI SellMASIMO CORP$18,365,000
-23.7%
201,418
-22.0%
2.67%
-30.3%
PDCO  PATTERSON COMPANIES INC$18,134,000
+3.8%
386,2320.0%2.64%
-5.1%
BIIB NewBIOGEN IDEC INC$15,685,00057,800
+100.0%
2.28%
CI  CIGNA CORPORATION$14,106,000
+14.3%
84,2700.0%2.05%
+4.5%
LH BuyLABORATORY CORP AMER HLDGS$13,102,000
+8.8%
85,000
+1.3%
1.90%
-0.5%
THC BuyTENET HEALTHCARE CORP$11,124,000
+149.2%
575,180
+128.2%
1.62%
+127.7%
LXRX BuyLEXICON PHARMACEUTICALS INC$10,243,000
+115.0%
622,655
+87.4%
1.49%
+96.4%
MNTA SellMOMENTA PHARMACEUTICALS INC$10,234,000
+1.3%
605,545
-20.0%
1.49%
-7.4%
LPNT SellLIFEPOINT HEALTH INC$10,053,000
-6.8%
149,714
-9.1%
1.46%
-14.8%
IPXL BuyIMPAX LABORATORIES INC$9,488,000
+40.4%
589,311
+10.3%
1.38%
+28.3%
OMI BuyOWENS & MINOR INC NEW$5,661,000
+12.2%
175,874
+20.6%
0.82%
+2.5%
ALXN NewALEXION PHARMACEUTICALS INC$4,903,00040,300
+100.0%
0.71%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-28,974
-100.0%
-0.62%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-267,050
-100.0%
-4.64%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BOSTON SCIENTIFIC CORP40Q1 20239.9%
BIO RAD LABS INC40Q1 20234.7%
BRISTOL-MYERS SQUIBB CO38Q3 202311.9%
BAXTER INTL INC34Q3 202312.7%
CARDINAL HEALTH INC34Q3 20238.1%
PERKINELMER INC33Q2 20216.3%
BIOGEN INC30Q3 20237.6%
ELEVANCE HEALTH INC30Q3 20235.6%
GILEAD SCIENCES INC29Q3 202314.0%
TENET HEALTHCARE CORP28Q3 20234.3%

View SECTOR GAMMA AS's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-05
13F-HR2023-11-06
13F-HR2023-08-09
13F-HR2023-05-12
13F-HR/A2023-02-08
13F-HR2023-02-07
13F-HR2022-11-09
13F-HR2022-08-05
13F-HR2022-05-06
13F-HR2022-02-08

View SECTOR GAMMA AS's complete filings history.

Compare quarters

Export SECTOR GAMMA AS's holdings